Showing results (1-10 of 374) with videos related to
Sort By:
Pageof 38
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2005
Therapeutic vaccines for prostate cancer: a review of clinical dataPhilip M Arlen, James L GulleyFuture Oncology (London, England)|March 25, 2006
Docetaxel-based regimens, the standard of care for metastatic androgen-insensitive prostate cancerPhilip M Arlen, James L GulleyAnti-Cancer Agents in Medicinal Chemistry|September 2, 2009
Current perspectives in prostate cancer vaccinesPhilip M Arlen, James L GulleyAmerican Journal of Therapeutics|May 11, 2004
Vaccine therapy for a patient with androgen-insensitive prostate cancer without evidence of measurable disease on scansPhilip M Arlen, James L Gulley, William DahutExperimental Biology and Medicine (Maywood, N.J.)|April 1, 2008
Paradigm shifts in cancer vaccine therapyJeffrey Schlom, James L Gulley, Philip M ArlenClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
Cancer vaccines: moving beyond current paradigmsJeffrey Schlom, Philip M Arlen, James L GulleyVaccine|June 19, 2007
Enhancing efficacy of therapeutic vaccinations by combination with other modalitiesJames L Gulley, Ravi A Madan, Philip M ArlenHematology/Oncology Clinics of North America|July 25, 2006
Immunotherapy for prostate cancer: what's the future?Philip M Arlen, William L Dahut, James L GulleyThe Oncologist|May 25, 2006
Therapeutic vaccines for prostate cancerChristopher P Tarassoff, Philip M Arlen, James L GulleyExpert Review of Vaccines|April 13, 2006
PSA-based vaccines for the treatment of prostate cancerRavi A Madan, James L Gulley, Philip M ArlenPageof 38